Review of Recommended and Potential Treatments of Neuropathy
April 1, 2021
This presentation will focus on guideline-directed recommendations, highlighting key studies comparing the different medications for DPN, CIPN, and PHN. Discussion of side effects and monitoring parameters will increase awareness among healthcare providers. Those who listen to this presentation will be able to recommend appropriate medication regimens to manage these disease states safely and effectively.
Target Audience
- Pharmacists
- Pharmacy technicians
Learning Objectives
Pharmacist learning objectives
- Compare and contrast pathophysiology of diabetic peripheral neuropathy (DPN), chemotherapy-induced peripheral neuropathy (CIPN) and post-herpetic neuralgia (PHN)
- Develop a medication regimen for a given patient who is diagnosed with DPN, CIPH, or PHN
- Discuss safety parameters for patients prescribed medications for neuropathies
Pharmacy technician learning objectives
- Compare and contrast causes of DPN, CIPN, and PHN
- Identify medications commonly used to treat neuropathy
Additional Information
Attachment | Size |
---|---|
Helpful Tips for Users.pdf | 157.72 KB |
Information for CE Credit - Review of Recommended and Potential Treatments of Neuropathy.docx | 125.03 KB |
ChristianaCare Health System
Newark, DE
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose
The presenter will discuss off-label use of drugs
Planning committee members
Sean Lasota, PharmD, BCACP
Clinical Pharmacy Specialist
ChristianaCare Health System
Avilash Bagchi, PharmD
PGY-1 Pharmacy Resident
ChristianaCare Health System
Course reviewer
James Lichauer, PharmD, BCPS, FASHP
PI Program Director, Pharmacy
Vizient, Inc.
Presenter
Avilash Bagchi, PharmD
PGY-1 Pharmacy Resident
ChristianaCare Health System
Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and ChristianaCare Health System. Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
Designation Statements:
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-21-111-L01-P
Universal Activity Number: JA0006103-9999-21-111-L01-T
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician